Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sukhdeep Dhaliwal

Oral & Maxillofacial Surgery Poulsbo, WA Doctor of Dentistry

NPI 1144396763 CMS profile 509864

19503 7Th Ave Ne # 100, Poulsbo, WA 98370

Open in the dashboard

General payments

$14,066

169 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sukhdeep Dhaliwal of Poulsbo, WA is reported in the CMS Open Payments database as having received $14,066 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,067 18
2024 General $847 13
2023 General $755 16
2022 General $1,631 32
2021 General $1,940 31
2020 General $609 11
2019 General $4,218 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sukhdeep Dhaliwal
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Sukhdeep Dhaliwal were reported at $4,067. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Sukhdeep Dhaliwal Oral & Maxillofacial Surgery median Middle half National median
2019 $4,218 $178 $56–$584 $163
2020 $609 $106 $38–$316 $114
2021 $1,940 $165 $57–$511 $132
2022 $1,631 $173 $63–$494 $149
2023 $755 $184 $62–$521 $160
2024 $847 $197 $65–$603 $164
2025 $4,067 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $6,969 62 payments
  2. Nobel Biocare USA $4,044 66 payments
  3. Salvin Dental Specialties, Inc. $1,241 9 payments
  4. Zimmer Biomet Holdings, Inc. $1,078 19 payments
  5. Zimvie Inc. $410 6 payments
  6. Stryker Corporation $159 1 payment
  7. Implant Direct Sybron International LLC $67 1 payment
  8. Allergan Inc. $62 3 payments
  9. DePuy Synthes Sales Inc. $37 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,934 147 payments
  2. Travel and Lodging $2,434 2 payments
  3. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $1,500 1 payment
  4. Education $482 6 payments
  5. Gift $401 7 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $172 4 payments
  7. Entertainment $144 2 payments
Products named General payments · program years 2019–2025
  1. NOBELACTIVE Dental implant $2,254 26 payments
  2. NOBELPARALLEL $2,229 25 payments
  3. NOBELACTIVE Dental implant $1,264 29 payments
  4. Tapered Screw Dental $420 3 payments
  5. NOBELREPLACE $268 6 payments
  6. NOBELPROCERA $268 6 payments
  7. NOBELSPEEDY $268 6 payments
  8. TSX Implants $210 2 payments
  9. Tapered Screw Dental $162 7 payments
  10. Puros $159 1 payment
  11. Other $1,002 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

644

Median for Oral Surgery (Dentist only): 288

Drug cost

$2,508

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

40.5%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 211 $702
Amoxicillin Generic 152 $554
Ibuprofen Generic 194 $554
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 50 $425
Clindamycin Hcl Generic 26 $211
Cephalexin Generic 11 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$6,732

Medicare's payments for the services billed

Medicare patients

28

Average age 76

Services billed

66

12 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 57%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record